<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0133057</article-id>
<article-id pub-id-type="publisher-id">PONE-D-15-05246</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Accuracy of Presepsin in Sepsis Diagnosis: A Systematic Review and Meta-Analysis</article-title>
<alt-title alt-title-type="running-head">Diagnostic Value of Presepsin in Sepsis: A Meta-Analysis</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Wu</surname>
<given-names>Jiayuan</given-names>
</name>
<xref rid="aff001" ref-type="aff"><sup>1</sup></xref>
<xref rid="cor001" ref-type="corresp">*</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Hu</surname>
<given-names>Liren</given-names>
</name>
<xref rid="aff002" ref-type="aff"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Zhang</surname>
<given-names>Gaohua</given-names>
</name>
<xref rid="aff002" ref-type="aff"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Wu</surname>
<given-names>Fenping</given-names>
</name>
<xref rid="aff003" ref-type="aff"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>He</surname>
<given-names>Taiping</given-names>
</name>
<xref rid="aff004" ref-type="aff"><sup>4</sup></xref>
<xref rid="cor001" ref-type="corresp">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Nutritional Department, The Affiliated Hospital of Guangdong Medical College, Zhanjiang, Guangdong, China</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Department of Epidemiology and Health Statistics, School of Public Health, Guangdong Medical College, Zhanjiang, Guangdong, China</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Department of Radiotherapy, The Seventh People's Hospital of Chengdu, The Oncology Hospital of Chengdu, Chengdu, Sichuan Province, China</addr-line></aff>
<aff id="aff004"><label>4</label> <addr-line>School of Public Health, Guangdong Medical College, Zhanjiang, Guangdong Province, China</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Groeneveld</surname>
<given-names>A.B. Johan</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>Erasmus Medical Centre, NETHERLANDS</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="con" id="contrib001">
<p>Conceived and designed the experiments: TH. Performed the experiments: JW FW. Analyzed the data: LH GZ. Contributed reagents/materials/analysis tools: LH. Wrote the paper: JW GZ.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">87537665@qq.com</email> (JW); <email xlink:type="simple">taipinghe@163.com</email> (TH)</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>20</day>
<month>7</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="collection">
<year>2015</year>
</pub-date>
<volume>10</volume>
<issue>7</issue>
<elocation-id>e0133057</elocation-id>
<history>
<date date-type="received">
<day>10</day>
<month>2</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>23</day>
<month>6</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-year>2015</copyright-year>
<copyright-holder>Wu et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0133057" xlink:type="simple"/>
<abstract>
<sec id="sec001">
<title>Objective</title>
<p>It’s difficult to differentiate sepsis from non-sepsis, especially non-infectious SIRS, because no good standard exists for proof of infection. Soluble CD14 subtype (sCD14-ST), recently re-named presepsin, was identified as a new marker for the diagnosis of sepsis in several reports. However, the findings were based on the results of individual clinical trials, rather than a comprehensive and overall estimation. Thus, we conducted this systematic review and meta-analysis to estimate the pooled accuracy of presepsin in patients with sepsis suspect.</p>
</sec>
<sec id="sec002">
<title>Methods</title>
<p>A comprehensive electronic search was performed via internet retrieval system up to 15 December 2014. Methodological quality assessment was applied by using the QUADAS2 tool. The diagnostic value of presepsin in sepsis was evaluated by using the pooled estimate of sensitivity, specificity, likelihood ratio, and diagnostic odds ratio, as well as summary receiver operating characteristics curve.</p>
</sec>
<sec id="sec003">
<title>Results</title>
<p>Nine studies with 10 trials and 2159 cases were included in the study. Only two trials had low concerns regarding applicability, whereas all trials were deemed to be at high risk of bias. Heterogeneity existed in the non-threshold effect, but not in the threshold effect. The pooled sensitivity of presepsin for sepsis was 0.78 (0.76–0.80), pooled specificity was 0.83 (0.80–0.85), pooled positive likelihood ratio was 4.63 (3.27–6.55), pooled negative likelihood ratio was 0.22 (0.16–0.30), and pooled diagnostic odds ratio was 21.73 (12.81–36.86). The area under curve of summary receiver operating characteristics curve was 0.89 (95%CI: 0.84 to 0.94) and Q* index was 0.82 (95%CI: 0.77 to 0.87).</p>
</sec>
<sec id="sec004">
<title>Conclusion</title>
<p>This meta-analysis demonstrates that presepsin had some superiority in the management of patients, and may be a helpful and valuable biomarker in early diagnosis of sepsis. However, presepsin showed a moderate diagnostic accuracy in differentiating sepsis from non-sepsis which prevented it from being recommended as a definitive test for diagnosing sepsis in isolation, but the results should be interpreted cautiously.</p>
</sec>
</abstract>
<funding-group>
<funding-statement>This study (TH) was funded by the Scientific and Technological Innovation Project of Educational Commission of Guangdong Province (Grant No. 2013KJCX0092). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="4"/>
<table-count count="6"/>
<page-count count="15"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability" xlink:type="simple">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec005" sec-type="intro">
<title>Introduction</title>
<p>Sepsis is a type of systematic inflammatory response syndrome (SIRS) caused by the invasion of pathogens or conditional pathogenic bacteria into the blood circulation. It can develop into severe sepsis, septic shock, and multiple organ failure. Sepsis occurs in 1%–2% of all hospitalized patients and accounts for as much as 25% of intensive care unit (ICU) cases [<xref rid="pone.0133057.ref001" ref-type="bibr">1</xref>]. When accompanied by organ system dysfunction or cardiovascular shock, severe sepsis or septic shock occurs and causes millions of deaths worldwide each year [<xref rid="pone.0133057.ref002" ref-type="bibr">2</xref>, <xref rid="pone.0133057.ref003" ref-type="bibr">3</xref>]. However, there is no good standard exists for proof of infection, no matter blood microbiological cultures which often lead to a late and imprecise report, or clinical symptoms which are non-specific and overlap with signs of SIRS without infection [<xref rid="pone.0133057.ref004" ref-type="bibr">4</xref>]. Delay of diagnosis and treatment with appropriate antimicrobial chemotherapy is the main reason for high morbidity and mortality associated with sepsis, thus looking for a reliable and timely biomarker for sepsis is of utmost importance [<xref rid="pone.0133057.ref005" ref-type="bibr">5</xref>]. At present, more than 178 markers have been found for sepsis, most of which are intermediate products of the inflammatory process and some are sepsis pro-inflammatory cytokines [<xref rid="pone.0133057.ref006" ref-type="bibr">6</xref>]. However, the most reliable biomarkers for precise diagnosis and prediction of the future process of patients suffering from severe sepsis or septic shock are still uncertain or are controversial [<xref rid="pone.0133057.ref007" ref-type="bibr">7</xref>].</p>
<p>As a glycoprotein expressed on monocytes and macrophages, cluster of differentiation 14 (CD14) serves as a receptor of the lipopolysaccharide (LPS)-lipopolysaccharide binding protein complexes and activates a series of signal transduction pathways and inflammatory cascades that finally lead to SIRS [<xref rid="pone.0133057.ref008" ref-type="bibr">8</xref>]. CD14 has two forms, namely, a membrane-bound CD14 (mCD14) and soluble CD14 (sCD14). sCD14 plays an important role in mediating the immune responses to LPS of CD14-negative cells, such as endothelial and epithelial cells. During inflammatory stress, sCD14 is cleaved in plasma, and the N-terminal fragment of 13 kDa has been identified as sCD14 subtype (sCD14-ST; also known as presepsin) [<xref rid="pone.0133057.ref009" ref-type="bibr">9</xref>].</p>
<p>In 2004, the value of presepsin in the diagnosis and evaluation of sepsis was discovered [<xref rid="pone.0133057.ref010" ref-type="bibr">10</xref>], and it has become an alternative biomarker to aid the diagnosis of sepsis. Since then, several studies have reported this compound as a new biomarker in the prediction of sepsis. However, there was a large variability regarding the results and sample sizes of these studies. For instance, the specificity in the report of Palmiere et al. [<xref rid="pone.0133057.ref011" ref-type="bibr">11</xref>] was only 0.44, whereas specificity was 0.98 in the study of Vodnik et al. [<xref rid="pone.0133057.ref012" ref-type="bibr">12</xref>]. Thus, the real value of presepsin in diagnosing sepsis is uncertain. Moreover, the findings of present reports were based on the results of individual clinical trials, and the literature lacks a pooled and robust appraisal of all the evidence for the diagnostic accuracy of presepsin testing. Systematic review and meta-analysis of the diagnostic efficiency are rigorous approaches for examining and synthesizing the evidence in the evaluation of the diagnostic and screening test [<xref rid="pone.0133057.ref013" ref-type="bibr">13</xref>]. Therefore, we conduct this systematic review and meta-analysis to evaluate the relationship between presepsin and sepsis to precisely estimate the diagnostic accuracy of the presepsin test.</p>
</sec>
<sec id="sec006" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="sec007">
<title>Literature Search</title>
<p>A comprehensive electronic search of the PubMed, Embase, Medline, Cochrane Library, and China National Knowledge Infrastructure (CNKI) was performed via the Internet retrieval system. No language limitation was indicated, and the articles’ inclusion period was until 15 December 2014. Search terms included (“presepsin,” or “sCD14-ST,” or “soluble CD14 subtype,”) and (“sepsis”) and (“diagnosis,” or “diagnostic value,” or “diagnostic biomarker”). In addition, content experts were contacted, and bibliographies of the relevant studies were reviewed to identify additional references. When multiple publications with the same or overlapping patient population from the same institution were identified, only the published report with the largest series was included. This meta-analysis was reported following the Preferred Reporting Items for Systematic Review and Meta-Analysis statement [<xref rid="pone.0133057.ref014" ref-type="bibr">14</xref>].</p>
</sec>
<sec id="sec008">
<title>Study Selection and Data Extraction</title>
<p>A study was eligible for our meta-analysis if it satisfied the following requirements: (1) its purpose was to evaluate or explore the diagnostic value of presepsin as a single index for differentiation between critically ill patients with sepsis from those of non-infection, such as patients with SIRS without infection, with or without healthy people; (2) data were available for calculating the true positives, false positive, false negatives, and true negatives; (3) applying the clinical criteria of the American College of Chest Physicians and Society of Critical Care Medicine (ACCP/SCCM) [<xref rid="pone.0133057.ref015" ref-type="bibr">15</xref>–<xref rid="pone.0133057.ref017" ref-type="bibr">17</xref>] as reference standard for defining sepsis and SIRS; and (4) with a prospective controlled design. The studies considered ineligible for the meta-analysis were as follows: reviews, conference abstracts, editorials, or case reports; duplicate studies; and those with insufficient information to calculate accuracy estimates.</p>
<p>All data extractions were independently completed by two authors (WJY and HLR) and were checked by a third reviewer (HTP). Any disagreement was resolved through discussion. The following data were extracted from each eligible study: authors, years of publication, locations of the study, selection and characteristics of the sample population, diagnostic test performed, cut-off value, sensitivity, and specificity.</p>
</sec>
<sec id="sec009">
<title>Quality Assessment</title>
<p>Each full-text article was reviewed independently by two authors (WJY and HLR) and scored with the Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool, and all disagreements were resolved by consensus. QUADAS-2 tool consists of four domains: patient selection, index test, reference standard, and flow/timing. “Risk of bias” was evaluated for all the domains, whereas “concerns regarding applicability” was evaluated for the first three domains. QUADAS-2 does not utilize a comprehensive quality score, but rather an overall judgment of “low,” “high,” or “unclear” risk. For judging the “risk of bias,” the reviewers analyzed all articles by answering each signaling question with a “yes,” “no,” or “unclear” and then by recording the following risk scores for each domain: “L” for “low risk of bias,” “H” for “high risk,” and “U” for “unclear.” In QUADAS-2, “applicability” means whether certain aspects of an individual research match the review’s question or not. The principle and method of judging the “concerns regarding applicability” are the same as those of the “risk of bias,” but without any signaling question. For overall judgment of “low risk of bias” or “low concern regarding applicability,” a study must be ranked “low” on all relevant domains. If a study receives a “high” or “unclear” rating in one or more domains, then it may be judged as “at risk of bias” or having “concerns regarding applicability” [<xref rid="pone.0133057.ref018" ref-type="bibr">18</xref>].</p>
</sec>
<sec id="sec010">
<title>Statistical Analysis</title>
<p>Data analysis was performed using the Meta-DiSc statistical software version 1.4 [<xref rid="pone.0133057.ref019" ref-type="bibr">19</xref>]. Sensitivity (Se), specificity (Sp), positive likelihood ratio (PLR), negative likelihood ratio (NLR), and diagnostic odds ratio (DOR) were computed for each study. DOR is a comprehensive measure for both Se and Sp or both PLR and NLR, and is regarded as an appropriate global measure for comparing the accuracy of different diagnostic tests, which is estimated by the following formula: (sensitivity/[1-sensitivity])/([1-specificity]/specificity) [<xref rid="pone.0133057.ref020" ref-type="bibr">20</xref>]. Pooled summary effect estimates were calculated using a random effects model (DerSimonian and Laird method) when high heterogeneity exists; otherwise, a fixed effect model (Mantel–Haenszel method) was used [<xref rid="pone.0133057.ref021" ref-type="bibr">21</xref>].</p>
<p>A summary receiver operating characteristics (SROC) curve was drawn to solve the inconsistency of various research results. Serving as global measures for the SROC curve, the area under curve (AUC), which could serve as a probability of correctly recognizing cases and non-cases by a diagnostic test, was also interpreted according to the following guidelines: low for 0.5–0.7, moderate for 0.7–0.9, and high for &gt; 0.9 [<xref rid="pone.0133057.ref022" ref-type="bibr">22</xref>, <xref rid="pone.0133057.ref023" ref-type="bibr">23</xref>]; as well as the Q* value, which is the point on the SROC curve where sensitivity equals specificity and is in the range 0–1 (1 indicates better test performance) [<xref rid="pone.0133057.ref024" ref-type="bibr">24</xref>, <xref rid="pone.0133057.ref025" ref-type="bibr">25</xref>].</p>
<p>The heterogeneity of a diagnostic test is caused by threshold or non-threshold effects in general. In this study, the heterogeneity caused by threshold effect was evaluated by the appearance of an SROC curve (a “shoulder-like” distribution suggested the existence of a threshold effect) and the calculation of Spearman correlation coefficient (<italic>ρ</italic>) between sensitivity logarithm and (1-specificity) logarithms. Furthermore, heterogeneity caused by non-threshold effect was quantified by applying the <italic>χ</italic><sup><italic>2</italic></sup> (for Se and Sp) and the Cochrane-<italic>Q</italic> test (for PLR, NLR, and DOR) and by determining the <italic>I</italic><sup>2</sup> metric. Statistical significance was set at <italic>P</italic> &lt; 0.05 or <italic>I</italic><sup>2</sup> &gt; 50% for the heterogeneity testing. A meta-regression was also performed to determine the factors for heterogeneity that have been influenced by the non-threshold effect. To eliminate the influence of the confounding factors, we also conducted a sensitivity analysis by calculating the pooled DOR and 95% CI after omitting the studies which including some possible confounding factors. Funnel plots, Begg’s rank correlation, and Egger’s linear regression method were also conducted to evaluate the potential publication bias through the STATA version 11.0 (STATA Corporation, College Station, TX, USA) [<xref rid="pone.0133057.ref026" ref-type="bibr">26</xref>, <xref rid="pone.0133057.ref027" ref-type="bibr">27</xref>].</p>
</sec>
</sec>
<sec id="sec011" sec-type="results">
<title>Results</title>
<sec id="sec012">
<title>Characteristics of included studies</title>
<p>Nine studies [<xref rid="pone.0133057.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0133057.ref012" ref-type="bibr">12</xref>, <xref rid="pone.0133057.ref028" ref-type="bibr">28</xref>–<xref rid="pone.0133057.ref034" ref-type="bibr">34</xref>] met the inclusion criteria for our meta-analysis, one [<xref rid="pone.0133057.ref034" ref-type="bibr">34</xref>] of which included two trials. Therefore, a total of 10 trials with 2159 cases were included (1320 patients with sepsis, 512 with SIRS of non-infectious origin, and 327 healthy people), the sample sizes of which ranged from 104 to 959. These 10 trials were eligible for this meta-analysis. These studies principally originated from Western Europe (2 from Italy [<xref rid="pone.0133057.ref029" ref-type="bibr">29</xref>, <xref rid="pone.0133057.ref033" ref-type="bibr">33</xref>], and 1 from Germany [<xref rid="pone.0133057.ref007" ref-type="bibr">7</xref>]) and Eastern Asia (3 from China [<xref rid="pone.0133057.ref030" ref-type="bibr">30</xref>–<xref rid="pone.0133057.ref032" ref-type="bibr">32</xref>], 1 from Korea [<xref rid="pone.0133057.ref028" ref-type="bibr">28</xref>], and 1 from Japan [<xref rid="pone.0133057.ref034" ref-type="bibr">34</xref>]). These studies along with one study from Serbia [<xref rid="pone.0133057.ref012" ref-type="bibr">12</xref>] were published between 2011 and 2014. Seven studies were written in English [<xref rid="pone.0133057.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0133057.ref012" ref-type="bibr">12</xref>, <xref rid="pone.0133057.ref028" ref-type="bibr">28</xref>, <xref rid="pone.0133057.ref029" ref-type="bibr">29</xref>, <xref rid="pone.0133057.ref032" ref-type="bibr">32</xref>–<xref rid="pone.0133057.ref034" ref-type="bibr">34</xref>], and the other two were written in Chinese [<xref rid="pone.0133057.ref030" ref-type="bibr">30</xref>, <xref rid="pone.0133057.ref031" ref-type="bibr">31</xref>]. All of the 9 studies were conducted in a prospective controlled design. Three studies were done in internal care unit (ICU) or critical care unit (CCU) [<xref rid="pone.0133057.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0133057.ref029" ref-type="bibr">29</xref>, <xref rid="pone.0133057.ref031" ref-type="bibr">31</xref>], five studies in emergency department (ED) [<xref rid="pone.0133057.ref012" ref-type="bibr">12</xref>, <xref rid="pone.0133057.ref028" ref-type="bibr">28</xref>, <xref rid="pone.0133057.ref031" ref-type="bibr">31</xref>, <xref rid="pone.0133057.ref032" ref-type="bibr">32</xref>, <xref rid="pone.0133057.ref033" ref-type="bibr">33</xref>], while only one in CCU and ED [<xref rid="pone.0133057.ref034" ref-type="bibr">34</xref>]. Four studies clearly stated that the blinding method was used in presepsin determination [<xref rid="pone.0133057.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0133057.ref028" ref-type="bibr">28</xref>, <xref rid="pone.0133057.ref031" ref-type="bibr">31</xref>, <xref rid="pone.0133057.ref033" ref-type="bibr">33</xref>], and three studies included only patients with non-infectious SIRS as controls [<xref rid="pone.0133057.ref031" ref-type="bibr">31</xref>, <xref rid="pone.0133057.ref033" ref-type="bibr">33</xref>, <xref rid="pone.0133057.ref034" ref-type="bibr">34</xref>], while the other six studies included both patients of SIRS without infection and healthy people in the control group [<xref rid="pone.0133057.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0133057.ref012" ref-type="bibr">12</xref>, <xref rid="pone.0133057.ref028" ref-type="bibr">28</xref>–<xref rid="pone.0133057.ref030" ref-type="bibr">30</xref>, <xref rid="pone.0133057.ref032" ref-type="bibr">32</xref>].</p>
<p>A summary of the characteristics of the 9 studies is outlined in <xref rid="pone.0133057.t001" ref-type="table">Table 1</xref>, and the clinical natures of each trial are shown in <xref rid="pone.0133057.t002" ref-type="table">Table 2</xref>. A flow diagram describes the details of the study selection progress (<xref rid="pone.0133057.g001" ref-type="fig">Fig 1</xref>).</p>
<fig id="pone.0133057.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0133057.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Flow diagram of the study selection process and specific reasons for exclusion in the meta-analysis.</title>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0133057.g001" position="float" xlink:type="simple"/>
</fig>
<table-wrap id="pone.0133057.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0133057.t001</object-id>
<label>Table 1</label> <caption><title>Characteristics of the included studies.</title></caption>
<alternatives>
<graphic id="pone.0133057.t001g" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0133057.t001" xlink:type="simple"/>
<table>
<colgroup span="1">
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
</colgroup>
<thead>
<tr>
<th align="left" rowspan="1" colspan="1">Author (year)</th>
<th align="left" rowspan="1" colspan="1">Nation</th>
<th align="left" rowspan="1" colspan="1">Language</th>
<th align="left" rowspan="1" colspan="1">Recruitment time</th>
<th align="left" rowspan="1" colspan="1">n</th>
<th align="left" rowspan="1" colspan="1">Male/female</th>
<th align="left" rowspan="1" colspan="1">T/C</th>
<th align="left" rowspan="1" colspan="1">Testing method</th>
<th align="left" rowspan="1" colspan="1">Blind</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Behnes M (2014) [<xref rid="pone.0133057.ref007" ref-type="bibr">7</xref>]</td>
<td align="left" rowspan="1" colspan="1">Germany</td>
<td align="left" rowspan="1" colspan="1">English</td>
<td align="left" rowspan="1" colspan="1">Since 2011.10</td>
<td align="left" rowspan="1" colspan="1">176</td>
<td align="left" rowspan="1" colspan="1">111/65</td>
<td align="left" rowspan="1" colspan="1">107/69</td>
<td align="left" rowspan="1" colspan="1">CLEIA</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Kweon OJ (2014) [<xref rid="pone.0133057.ref028" ref-type="bibr">28</xref>]</td>
<td align="left" rowspan="1" colspan="1">Korea</td>
<td align="left" rowspan="1" colspan="1">English</td>
<td align="left" rowspan="1" colspan="1">2012.9~2013.7</td>
<td align="left" rowspan="1" colspan="1">118</td>
<td align="left" rowspan="1" colspan="1">59/59</td>
<td align="left" rowspan="1" colspan="1">73/45</td>
<td align="left" rowspan="1" colspan="1">CLEIA</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Sargentini V (2014) [<xref rid="pone.0133057.ref029" ref-type="bibr">29</xref>]</td>
<td align="left" rowspan="1" colspan="1">Italy</td>
<td align="left" rowspan="1" colspan="1">English</td>
<td align="left" rowspan="1" colspan="1">2013.3~2013.7</td>
<td align="left" rowspan="1" colspan="1">104</td>
<td align="left" rowspan="1" colspan="1">47/57</td>
<td align="left" rowspan="1" colspan="1">60/44</td>
<td align="left" rowspan="1" colspan="1">CLEIA</td>
<td align="left" rowspan="1" colspan="1">NR</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Su MH (2014) [<xref rid="pone.0133057.ref030" ref-type="bibr">30</xref>]</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">Chinese</td>
<td align="left" rowspan="1" colspan="1">2012.11~2013.8</td>
<td align="left" rowspan="1" colspan="1">115</td>
<td align="left" rowspan="1" colspan="1">65/50</td>
<td align="left" rowspan="1" colspan="1">72/43</td>
<td align="left" rowspan="1" colspan="1">CLEIA</td>
<td align="left" rowspan="1" colspan="1">NR</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Yu J (2014) [<xref rid="pone.0133057.ref031" ref-type="bibr">31</xref>]</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">Chinese</td>
<td align="left" rowspan="1" colspan="1">2012.6~2012.12</td>
<td align="left" rowspan="1" colspan="1">176</td>
<td align="left" rowspan="1" colspan="1">119/57</td>
<td align="left" rowspan="1" colspan="1">63/113</td>
<td align="left" rowspan="1" colspan="1">CLEIA</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Liu B (2013) [<xref rid="pone.0133057.ref032" ref-type="bibr">32</xref>]</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">English</td>
<td align="left" rowspan="1" colspan="1">2011.12~2012.10</td>
<td align="left" rowspan="1" colspan="1">959</td>
<td align="left" rowspan="1" colspan="1">570/389</td>
<td align="left" rowspan="1" colspan="1">680/279</td>
<td align="left" rowspan="1" colspan="1">CLEIA</td>
<td align="left" rowspan="1" colspan="1">NR</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Ulla M (2013) [<xref rid="pone.0133057.ref033" ref-type="bibr">33</xref>]</td>
<td align="left" rowspan="1" colspan="1">Italy</td>
<td align="left" rowspan="1" colspan="1">English</td>
<td align="left" rowspan="1" colspan="1">2012.1~2013.1</td>
<td align="left" rowspan="1" colspan="1">189</td>
<td align="left" rowspan="1" colspan="1">116/73</td>
<td align="left" rowspan="1" colspan="1">106/83</td>
<td align="left" rowspan="1" colspan="1">CLEIA</td>
<td align="left" rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Vodnik T (2013) [<xref rid="pone.0133057.ref012" ref-type="bibr">12</xref>]</td>
<td align="left" rowspan="1" colspan="1">Serbia</td>
<td align="left" rowspan="1" colspan="1">English</td>
<td align="left" rowspan="1" colspan="1">NR</td>
<td align="left" rowspan="1" colspan="1">130</td>
<td align="left" rowspan="1" colspan="1">71/59</td>
<td align="left" rowspan="1" colspan="1">30/100</td>
<td align="left" rowspan="1" colspan="1">CLEIA</td>
<td align="left" rowspan="1" colspan="1">NR</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Shozushima T (2011) [<xref rid="pone.0133057.ref034" ref-type="bibr">34</xref>]</td>
<td align="left" rowspan="1" colspan="1">Japan</td>
<td align="left" rowspan="1" colspan="1">English</td>
<td align="left" rowspan="1" colspan="1">2009.8~2010.7</td>
<td align="left" rowspan="1" colspan="1">192</td>
<td align="left" rowspan="1" colspan="1">117/75</td>
<td align="left" rowspan="1" colspan="1">129/63</td>
<td align="left" rowspan="1" colspan="1">CLEIA</td>
<td align="left" rowspan="1" colspan="1">NR</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p>NR: none reported; T/C: test group/control group; CLEIA: chemiluminescent enzyme immunoassay.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="pone.0133057.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0133057.t002</object-id>
<label>Table 2</label> <caption><title>Clinical nature of the included studies.</title></caption>
<alternatives>
<graphic id="pone.0133057.t002g" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0133057.t002" xlink:type="simple"/>
<table>
<colgroup span="1">
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
</colgroup>
<thead>
<tr>
<th align="left" rowspan="1" colspan="1">Author (year)</th>
<th align="left" rowspan="1" colspan="1">Setting</th>
<th align="left" rowspan="1" colspan="1">Admission category</th>
<th align="left" rowspan="1" colspan="1">Severity</th>
<th align="left" rowspan="1" colspan="1">Controls</th>
<th align="left" rowspan="1" colspan="1">Sampling time</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Behnes M (2014) [<xref rid="pone.0133057.ref007" ref-type="bibr">7</xref>]</td>
<td align="left" rowspan="1" colspan="1">ICU</td>
<td align="left" rowspan="1" colspan="1">Medical</td>
<td align="left" rowspan="1" colspan="1">Sepsis, severe sepsis, sepsis shock</td>
<td align="left" rowspan="1" colspan="1">SIRS without infection, health</td>
<td align="left" rowspan="1" colspan="1">At clinical onset</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Kweon OJ(2014) [<xref rid="pone.0133057.ref028" ref-type="bibr">28</xref>]</td>
<td align="left" rowspan="1" colspan="1">ED</td>
<td align="left" rowspan="1" colspan="1">Medical</td>
<td align="left" rowspan="1" colspan="1">Sepsis, severe sepsis, sepsis shock</td>
<td align="left" rowspan="1" colspan="1">SIRS without infection, health</td>
<td align="left" rowspan="1" colspan="1">At admission</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Sargentini V (2014) [<xref rid="pone.0133057.ref029" ref-type="bibr">29</xref>]</td>
<td align="left" rowspan="1" colspan="1">CCU</td>
<td align="left" rowspan="1" colspan="1">Medical, traumatic</td>
<td align="left" rowspan="1" colspan="1">Sepsis, severe sepsis</td>
<td align="left" rowspan="1" colspan="1">SIRS without infection, health</td>
<td align="left" rowspan="1" colspan="1">At admission</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Su MH (2014) [<xref rid="pone.0133057.ref030" ref-type="bibr">30</xref>]</td>
<td align="left" rowspan="1" colspan="1">ED</td>
<td align="left" rowspan="1" colspan="1">Medical</td>
<td align="left" rowspan="1" colspan="1">Sepsis, severe sepsis, sepsis shock</td>
<td align="left" rowspan="1" colspan="1">SIRS without infection, health</td>
<td align="left" rowspan="1" colspan="1">Before any treatment</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Yu J (2014) [<xref rid="pone.0133057.ref031" ref-type="bibr">31</xref>]</td>
<td align="left" rowspan="1" colspan="1">ICU</td>
<td align="left" rowspan="1" colspan="1">Traumatic</td>
<td align="left" rowspan="1" colspan="1">Sepsis</td>
<td align="left" rowspan="1" colspan="1">SIRS without infection</td>
<td align="left" rowspan="1" colspan="1">At clinical onset</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Liu B (2013) [<xref rid="pone.0133057.ref032" ref-type="bibr">32</xref>]</td>
<td align="left" rowspan="1" colspan="1">ED</td>
<td align="left" rowspan="1" colspan="1">Medical</td>
<td align="left" rowspan="1" colspan="1">Sepsis, severe sepsis, sepsis shock</td>
<td align="left" rowspan="1" colspan="1">SIRS without infection, health</td>
<td align="left" rowspan="1" colspan="1">At admission</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Ulla M (2013) [<xref rid="pone.0133057.ref033" ref-type="bibr">33</xref>]</td>
<td align="left" rowspan="1" colspan="1">ED</td>
<td align="left" rowspan="1" colspan="1">Medical, surgical, traumatic</td>
<td align="left" rowspan="1" colspan="1">Sepsis, severe sepsis,sepsis shock</td>
<td align="left" rowspan="1" colspan="1">SIRS without infection</td>
<td align="left" rowspan="1" colspan="1">At first medical evaluation</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Vodnik T (2013) [<xref rid="pone.0133057.ref012" ref-type="bibr">12</xref>]</td>
<td align="left" rowspan="1" colspan="1">ED</td>
<td align="left" rowspan="1" colspan="1">Surgical</td>
<td align="left" rowspan="1" colspan="1">Sepsis, severe sepsis, sepsis shock</td>
<td align="left" rowspan="1" colspan="1">SIRS without infection, health</td>
<td align="left" rowspan="1" colspan="1">At admission</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Shozushima T (2011) [<xref rid="pone.0133057.ref034" ref-type="bibr">34</xref>]</td>
<td align="left" rowspan="1" colspan="1">CCU, ED</td>
<td align="left" rowspan="1" colspan="1">Medical, traumatic</td>
<td align="left" rowspan="1" colspan="1">Sepsis, severe sepsis</td>
<td align="left" rowspan="1" colspan="1">SIRS without infection</td>
<td align="left" rowspan="1" colspan="1">At admission</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t002fn001"><p>NR: none reported; ICU: internal care unit; ED: emergency department; CCU: critical care unit; SIRS: systemic inflammatory response syndrome; ACCP/SCCM: the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec013">
<title>Results of quality assessment</title>
<p>The results of the quality assessment are listed in <xref rid="pone.0133057.t003" ref-type="table">Table 3</xref>, and the details are presented in <xref rid="pone.0133057.s002" ref-type="supplementary-material">S1 Table</xref>. When the QUADAS-2 tool was used to assess the risk of bias in the 10 trials, 7 trials showed problems in patient selection, 5 showed problems in reference standard, 4 showed problems in study flow, and all 10 trials showed problems in the index test. Moreover, when the concerns of applicability were considered, 8 trials showed problems in patient selection, but the reference standard and index test were used appropriately in all trials.</p>
<table-wrap id="pone.0133057.t003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0133057.t003</object-id>
<label>Table 3</label> <caption><title>Results of QUADAS-2 quality assessment for each trial.</title></caption>
<alternatives>
<graphic id="pone.0133057.t003g" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0133057.t003" xlink:type="simple"/>
<table>
<colgroup span="1">
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
</colgroup>
<thead>
<tr>
<th rowspan="2" align="left" colspan="1">Studies</th>
<th colspan="5" align="center" rowspan="1">Risk of bias</th>
<th colspan="4" align="center" rowspan="1">Concerns of applicability</th>
</tr>
<tr>
<th align="left" rowspan="1" colspan="1">Patient selection</th>
<th align="left" rowspan="1" colspan="1">Index test</th>
<th align="left" rowspan="1" colspan="1">Reference standard</th>
<th align="left" rowspan="1" colspan="1">Flow and time</th>
<th align="left" rowspan="1" colspan="1">Overall</th>
<th align="left" rowspan="1" colspan="1">Patient</th>
<th align="left" rowspan="1" colspan="1">Index test</th>
<th align="left" rowspan="1" colspan="1">Reference standard</th>
<th align="left" rowspan="1" colspan="1">Overall</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Behnes M (2014) [<xref rid="pone.0133057.ref007" ref-type="bibr">7</xref>]</td>
<td align="left" rowspan="1" colspan="1">?</td>
<td align="left" rowspan="1" colspan="1">?</td>
<td align="left" rowspan="1" colspan="1">☺</td>
<td align="left" rowspan="1" colspan="1">☺</td>
<td align="left" rowspan="1" colspan="1">High</td>
<td align="left" rowspan="1" colspan="1">☹</td>
<td align="left" rowspan="1" colspan="1">☺</td>
<td align="left" rowspan="1" colspan="1">☺</td>
<td align="left" rowspan="1" colspan="1">High</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Kweon OJ (2014) [<xref rid="pone.0133057.ref028" ref-type="bibr">28</xref>]</td>
<td align="left" rowspan="1" colspan="1">☺</td>
<td align="left" rowspan="1" colspan="1">?</td>
<td align="left" rowspan="1" colspan="1">☺</td>
<td align="left" rowspan="1" colspan="1">☺</td>
<td align="left" rowspan="1" colspan="1">High</td>
<td align="left" rowspan="1" colspan="1">☹</td>
<td align="left" rowspan="1" colspan="1">☺</td>
<td align="left" rowspan="1" colspan="1">☺</td>
<td align="left" rowspan="1" colspan="1">High</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Sargentini V (2014) [<xref rid="pone.0133057.ref029" ref-type="bibr">29</xref>]</td>
<td align="left" rowspan="1" colspan="1">☺</td>
<td align="left" rowspan="1" colspan="1">?</td>
<td align="left" rowspan="1" colspan="1">?</td>
<td align="left" rowspan="1" colspan="1">☺</td>
<td align="left" rowspan="1" colspan="1">High</td>
<td align="left" rowspan="1" colspan="1">☹</td>
<td align="left" rowspan="1" colspan="1">☺</td>
<td align="left" rowspan="1" colspan="1">☺</td>
<td align="left" rowspan="1" colspan="1">High</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Su MH (2014) [<xref rid="pone.0133057.ref030" ref-type="bibr">30</xref>]</td>
<td align="left" rowspan="1" colspan="1">?</td>
<td align="left" rowspan="1" colspan="1">?</td>
<td align="left" rowspan="1" colspan="1">☺</td>
<td align="left" rowspan="1" colspan="1">?</td>
<td align="left" rowspan="1" colspan="1">High</td>
<td align="left" rowspan="1" colspan="1">☹</td>
<td align="left" rowspan="1" colspan="1">☺</td>
<td align="left" rowspan="1" colspan="1">☺</td>
<td align="left" rowspan="1" colspan="1">High</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Yu J (2014) [<xref rid="pone.0133057.ref031" ref-type="bibr">31</xref>]</td>
<td align="left" rowspan="1" colspan="1">☺</td>
<td align="left" rowspan="1" colspan="1">?</td>
<td align="left" rowspan="1" colspan="1">☺</td>
<td align="left" rowspan="1" colspan="1">☺</td>
<td align="left" rowspan="1" colspan="1">High</td>
<td align="left" rowspan="1" colspan="1">☺</td>
<td align="left" rowspan="1" colspan="1">☺</td>
<td align="left" rowspan="1" colspan="1">☺</td>
<td align="left" rowspan="1" colspan="1">Low</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Liu B (2013) [<xref rid="pone.0133057.ref032" ref-type="bibr">32</xref>]</td>
<td align="left" rowspan="1" colspan="1">?</td>
<td align="left" rowspan="1" colspan="1">☹</td>
<td align="left" rowspan="1" colspan="1">?</td>
<td align="left" rowspan="1" colspan="1">?</td>
<td align="left" rowspan="1" colspan="1">High</td>
<td align="left" rowspan="1" colspan="1">☹</td>
<td align="left" rowspan="1" colspan="1">☺</td>
<td align="left" rowspan="1" colspan="1">☺</td>
<td align="left" rowspan="1" colspan="1">High</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Ulla M (2013) [<xref rid="pone.0133057.ref033" ref-type="bibr">33</xref>]</td>
<td align="left" rowspan="1" colspan="1">?</td>
<td align="left" rowspan="1" colspan="1">?</td>
<td align="left" rowspan="1" colspan="1">☺</td>
<td align="left" rowspan="1" colspan="1">?</td>
<td align="left" rowspan="1" colspan="1">High</td>
<td align="left" rowspan="1" colspan="1">☺</td>
<td align="left" rowspan="1" colspan="1">☺</td>
<td align="left" rowspan="1" colspan="1">☺</td>
<td align="left" rowspan="1" colspan="1">Low</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Vodnik T (2013) [<xref rid="pone.0133057.ref012" ref-type="bibr">12</xref>]</td>
<td align="left" rowspan="1" colspan="1">☹</td>
<td align="left" rowspan="1" colspan="1">☹</td>
<td align="left" rowspan="1" colspan="1">?</td>
<td align="left" rowspan="1" colspan="1">?</td>
<td align="left" rowspan="1" colspan="1">High</td>
<td align="left" rowspan="1" colspan="1">☹</td>
<td align="left" rowspan="1" colspan="1">☺</td>
<td align="left" rowspan="1" colspan="1">☺</td>
<td align="left" rowspan="1" colspan="1">High</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Shozushima T (2011)<xref rid="t003fn001" ref-type="table-fn"><sup>a</sup></xref> [<xref rid="pone.0133057.ref034" ref-type="bibr">34</xref>]</td>
<td align="left" rowspan="1" colspan="1">?</td>
<td align="left" rowspan="1" colspan="1">?</td>
<td align="left" rowspan="1" colspan="1">?</td>
<td align="left" rowspan="1" colspan="1">☺</td>
<td align="left" rowspan="1" colspan="1">High</td>
<td align="left" rowspan="1" colspan="1">☹</td>
<td align="left" rowspan="1" colspan="1">☺</td>
<td align="left" rowspan="1" colspan="1">☺</td>
<td align="left" rowspan="1" colspan="1">High</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Shozushima T (2011)<xref rid="t003fn002" ref-type="table-fn"><sup>b</sup></xref> [<xref rid="pone.0133057.ref034" ref-type="bibr">34</xref>]</td>
<td align="left" rowspan="1" colspan="1">?</td>
<td align="left" rowspan="1" colspan="1">?</td>
<td align="left" rowspan="1" colspan="1">?</td>
<td align="left" rowspan="1" colspan="1">☺</td>
<td align="left" rowspan="1" colspan="1">High</td>
<td align="left" rowspan="1" colspan="1">☹</td>
<td align="left" rowspan="1" colspan="1">☺</td>
<td align="left" rowspan="1" colspan="1">☺</td>
<td align="left" rowspan="1" colspan="1">High</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t003fn001"><p><sup>a</sup> Results of first of two trials in this article</p></fn>
<fn id="t003fn002"><p><sup>b</sup> Results of second of two trials in this article</p></fn>
<fn id="t003fn003"><p>☺ low risk; ☹ high risk;? unclear risk.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>In general, all trials were at risk of bias. Two trials had low concerns regarding applicability, whereas the other 8 trials showed problems regarding applicability.</p>
</sec>
<sec id="sec014">
<title>Results of heterogeneity test</title>
<p>From the appearance of the SROC curve (<xref rid="pone.0133057.g002" ref-type="fig">Fig 2</xref>) and the estimation of the Spearman correlation coefficient (<italic>ρ</italic> = –0.261, <italic>P</italic> = 0.467), we could conclude that no threshold effect existed.</p>
<fig id="pone.0133057.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0133057.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Summary receiver operator characteristic plots with 95% CIs of sensitivity against (1-specificity) of presepsin testing for sepsis.</title>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0133057.g002" position="float" xlink:type="simple"/>
</fig>
<p>However, when non-threshold effect was investigated, significant heterogeneity was measured in the overall Se (<italic>χ</italic><sup><italic>2</italic></sup> = 83.47, <italic>P</italic> &lt; 0.001, <italic>I</italic><sup>2</sup> = 89.2%), Sp (<italic>χ</italic><sup><italic>2</italic></sup> = 56.40, <italic>P</italic> &lt; 0.001, <italic>I</italic><sup>2</sup> = 84.0%), PLR (Cochran-<italic>Q</italic> = 46.13, <italic>P</italic> &lt; 0.001, <italic>I</italic><sup>2</sup> = 80.5%), NLR (Cochran-<italic>Q</italic> = 45.49, <italic>P</italic> &lt; 0.001, <italic>I</italic><sup>2</sup> = 80.2%), and DOR (Cochran-<italic>Q</italic> = 35.15, <italic>P</italic> = 0.0001, <italic>I</italic><sup>2</sup> = 74.4%). Therefore, a random-effect model was applied for data synthesis. To determine the sources of heterogeneity, we used location, number of cases, blind, cutoff value, setting, admission category, and control’s component as variables in the meta-regression analysis. The results are shown in <xref rid="pone.0133057.t004" ref-type="table">Table 4</xref>. Results showed that the heterogeneity could not be explained by meta regression analysis.</p>
<table-wrap id="pone.0133057.t004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0133057.t004</object-id>
<label>Table 4</label> <caption><title>Possible sources of heterogeneity of meta-analysis (Results of meta-regression analysis).</title></caption>
<alternatives>
<graphic id="pone.0133057.t004g" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0133057.t004" xlink:type="simple"/>
<table>
<colgroup span="1">
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
</colgroup>
<thead>
<tr>
<th align="left" rowspan="1" colspan="1">Variance</th>
<th align="left" rowspan="1" colspan="1">Coefficient</th>
<th align="left" rowspan="1" colspan="1">Standard error</th>
<th align="left" rowspan="1" colspan="1"><italic>P</italic> value</th>
<th align="left" rowspan="1" colspan="1">RDOR (95% <italic>CI</italic>)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Location (Europe vs. Asia)</td>
<td align="char" char="." rowspan="1" colspan="1">2.341</td>
<td align="char" char="." rowspan="1" colspan="1">0.8083</td>
<td align="char" char="." rowspan="1" colspan="1">0.0626</td>
<td align="left" rowspan="1" colspan="1">10.40 (0.79; 136.26)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">No. of cases (&gt; 150 vs. &lt; 150)</td>
<td align="char" char="." rowspan="1" colspan="1">- 0.601</td>
<td align="char" char="." rowspan="1" colspan="1">0.8330</td>
<td align="char" char="." rowspan="1" colspan="1">0.5227</td>
<td align="left" rowspan="1" colspan="1">0.55 (0.04; 7.77)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Cut-off value (≥ 600 pg/ml vs. &lt; 600 pg/ml)</td>
<td align="char" char="." rowspan="1" colspan="1">0.628</td>
<td align="char" char="." rowspan="1" colspan="1">1.0447</td>
<td align="char" char="." rowspan="1" colspan="1">0.5698</td>
<td align="left" rowspan="1" colspan="1">1.87 (0.15; 24.15)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Blind (Blind vs. NR)</td>
<td align="char" char="." rowspan="1" colspan="1">0.651</td>
<td align="char" char="." rowspan="1" colspan="1">0.8551</td>
<td align="char" char="." rowspan="1" colspan="1">0.4756</td>
<td align="left" rowspan="1" colspan="1">1.92 (0.24; 15.53)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Setting (ICU/CCU vs. ED vs. CCU + ED)</td>
<td align="char" char="." rowspan="1" colspan="1">- 0.533</td>
<td align="char" char="." rowspan="1" colspan="1">0.2762</td>
<td align="char" char="." rowspan="1" colspan="1">0.1494</td>
<td align="left" rowspan="1" colspan="1">0.59 (0.24; 1.41)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Admission category (only medical vs. others)</td>
<td align="char" char="." rowspan="1" colspan="1">0.983</td>
<td align="char" char="." rowspan="1" colspan="1">0.9208</td>
<td align="char" char="." rowspan="1" colspan="1">0.3642</td>
<td align="left" rowspan="1" colspan="1">2.67 (0.14; 50.04)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Controls (SIRS vs. SIRS + healthy)</td>
<td align="char" char="." rowspan="1" colspan="1">1.555</td>
<td align="char" char="." rowspan="1" colspan="1">1.0332</td>
<td align="char" char="." rowspan="1" colspan="1">0.2294</td>
<td align="left" rowspan="1" colspan="1">4.73 (0.18; 126.84)</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t004fn001"><p>RDOR: relative diagnostic odds ratio; CI: confidence interval; NR: none reported; ICU: internal care unit; ED: emergency department; CCU: critical care unit; SIRS: systemic inflammatory response syndrome.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec015">
<title>Results of meta-analysis</title>
<p>For the 9 studies that represented 10 trials, cutoff values were ranged from 317 pg/ml to 700 pg/ml in each trial. The reported sensitivity of presepsin diagnosing sepsis ranged from 0.71 to 1.00, the specificity ranged from 0.62 to 0.98, the positive likelihood ratio ranged from 1.71 to 39.75, the negative likelihood ratio ranged from 0.02 to 0.34, and the diagnostic odds ratio ranged from 6.09 to 2403.40.</p>
<p>Overall, the pooled Se of presepsin for sepsis was 0.78 (95%CI: 0.76 to 0.80) (<xref rid="pone.0133057.g003" ref-type="fig">Fig 3A</xref>), pooled Sp was 0.83 (95%CI: 0.80 to 0.85) (<xref rid="pone.0133057.g003" ref-type="fig">Fig 3B</xref>), pooled PLR was 4.63 (95%CI: 3.27 to 6.55) (<xref rid="pone.0133057.g003" ref-type="fig">Fig 3C</xref>), pooled NLR was 0.22 (95%CI: 0.16 to 0.30) (<xref rid="pone.0133057.g003" ref-type="fig">Fig 3D</xref>), and pooled DOR was 21.73 (95%CI: 12.81 to 36.86) (<xref rid="pone.0133057.g003" ref-type="fig">Fig 3E</xref>). In addition, the AUC of SROC curve was 0.89 (95%CI: 0.84 to 0.94), and Q* index was 0.82 (95%CI: 0.77 to 0.87) (<xref rid="pone.0133057.g002" ref-type="fig">Fig 2</xref>).</p>
<fig id="pone.0133057.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0133057.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Forest plots of the pooled results for presepsin in diagnosing sepsis.</title>
<p>Each circle shows the point estimate of the outcome from each included trial. (A) Forrest plot to assess the pooled sensitivity. (B) Forrest plot to assess the pooled specificity. (C) Forrest plot to assess the pooled positive likelihood ratio. (D) Forrest plot to assess the pooled negative likelihood ratio. (E) Forrest plot to assess the pooled diagnostic odds ratio.</p>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0133057.g003" position="float" xlink:type="simple"/>
</fig>
<p>The results of each trial, and overall outcomes were listed in <xref rid="pone.0133057.t005" ref-type="table">Table 5</xref>.</p>
<table-wrap id="pone.0133057.t005" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0133057.t005</object-id>
<label>Table 5</label> <caption><title>The diagnostic parameters of presepsin for sepsis in the included trials, and overall outcome.</title></caption>
<alternatives>
<graphic id="pone.0133057.t005g" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0133057.t005" xlink:type="simple"/>
<table>
<colgroup span="1">
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
</colgroup>
<thead>
<tr>
<th align="left" rowspan="1" colspan="1">Study</th>
<th align="left" rowspan="1" colspan="1">Cut-off (pg/ml)</th>
<th align="left" rowspan="1" colspan="1">TP</th>
<th align="left" rowspan="1" colspan="1">FP</th>
<th align="left" rowspan="1" colspan="1">FN</th>
<th align="left" rowspan="1" colspan="1">TN</th>
<th align="left" rowspan="1" colspan="1">Se</th>
<th align="left" rowspan="1" colspan="1">Sp</th>
<th align="left" rowspan="1" colspan="1">PLR</th>
<th align="left" rowspan="1" colspan="1">NLR</th>
<th align="left" rowspan="1" colspan="1">DOR</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Behnes (2014) [<xref rid="pone.0133057.ref007" ref-type="bibr">7</xref>]</td>
<td align="left" rowspan="1" colspan="1">700</td>
<td align="left" rowspan="1" colspan="1">97</td>
<td align="left" rowspan="1" colspan="1">16</td>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">53</td>
<td align="left" rowspan="1" colspan="1">0.91 (0.83–0.95)</td>
<td align="left" rowspan="1" colspan="1">0.77 (0.65–0.86)</td>
<td align="left" rowspan="1" colspan="1">3.91 (2.53–6.03)</td>
<td align="left" rowspan="1" colspan="1">0.12 (0.07–0.22)</td>
<td align="left" rowspan="1" colspan="1">32.13 (13.62–75.79)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Kweon (2014) [<xref rid="pone.0133057.ref028" ref-type="bibr">28</xref>]</td>
<td align="left" rowspan="1" colspan="1">430</td>
<td align="left" rowspan="1" colspan="1">64</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">9</td>
<td align="left" rowspan="1" colspan="1">37</td>
<td align="left" rowspan="1" colspan="1">0.88 (0.78–0.94)</td>
<td align="left" rowspan="1" colspan="1">0.82 (0.68–0.92)</td>
<td align="left" rowspan="1" colspan="1">4.93 (2.62–9.30)</td>
<td align="left" rowspan="1" colspan="1">0.15 (0.08–0.28)</td>
<td align="left" rowspan="1" colspan="1">32.89 (11.69–92.57)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Sargentini (2014) [<xref rid="pone.0133057.ref029" ref-type="bibr">29</xref>]</td>
<td align="left" rowspan="1" colspan="1">600</td>
<td align="left" rowspan="1" colspan="1">52</td>
<td align="left" rowspan="1" colspan="1">12</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">32</td>
<td align="left" rowspan="1" colspan="1">0.87 (0.75–0.94)</td>
<td align="left" rowspan="1" colspan="1">0.73 (0.57–0.85)</td>
<td align="left" rowspan="1" colspan="1">3.18 (1.94–5.20)</td>
<td align="left" rowspan="1" colspan="1">0.18 (0.09–0.36)</td>
<td align="left" rowspan="1" colspan="1">17.33 (6.40–46.98)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Su M (2014) [<xref rid="pone.0133057.ref030" ref-type="bibr">30</xref>]</td>
<td align="left" rowspan="1" colspan="1">407</td>
<td align="left" rowspan="1" colspan="1">71</td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">39</td>
<td align="left" rowspan="1" colspan="1">0.99 (0.93–1.00)</td>
<td align="left" rowspan="1" colspan="1">0.91 (0.78–0.97)</td>
<td align="left" rowspan="1" colspan="1">10.60 (4.17–26.97)</td>
<td align="left" rowspan="1" colspan="1">0.02 (0.00–0.11)</td>
<td align="left" rowspan="1" colspan="1">692.25 (74.75–6411.24)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Yu J (2014) [<xref rid="pone.0133057.ref031" ref-type="bibr">31</xref>]</td>
<td align="left" rowspan="1" colspan="1">540</td>
<td align="left" rowspan="1" colspan="1">46</td>
<td align="left" rowspan="1" colspan="1">15</td>
<td align="left" rowspan="1" colspan="1">17</td>
<td align="left" rowspan="1" colspan="1">98</td>
<td align="left" rowspan="1" colspan="1">0.73 (0.60–0.83)</td>
<td align="left" rowspan="1" colspan="1">0.87 (0.79–0.92)</td>
<td align="left" rowspan="1" colspan="1">5.50 (3.35–9.02)</td>
<td align="left" rowspan="1" colspan="1">0.31 (0.21–0.47)</td>
<td align="left" rowspan="1" colspan="1">17.68 (8.12–38.48)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Liu B (2013) [<xref rid="pone.0133057.ref032" ref-type="bibr">32</xref>]</td>
<td align="left" rowspan="1" colspan="1">317</td>
<td align="left" rowspan="1" colspan="1">481</td>
<td align="left" rowspan="1" colspan="1">40</td>
<td align="left" rowspan="1" colspan="1">199</td>
<td align="left" rowspan="1" colspan="1">239</td>
<td align="left" rowspan="1" colspan="1">0.71 (0.67–0.74)</td>
<td align="left" rowspan="1" colspan="1">0.86 (0.81–0.90)</td>
<td align="left" rowspan="1" colspan="1">4.93 (3.69–6.60)</td>
<td align="left" rowspan="1" colspan="1">0.34 (0.30–0.39)</td>
<td align="left" rowspan="1" colspan="1">14.44 (9.94–20.98)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Ulla M (2013) [<xref rid="pone.0133057.ref033" ref-type="bibr">33</xref>]</td>
<td align="left" rowspan="1" colspan="1">600</td>
<td align="left" rowspan="1" colspan="1">84</td>
<td align="left" rowspan="1" colspan="1">32</td>
<td align="left" rowspan="1" colspan="1">22</td>
<td align="left" rowspan="1" colspan="1">51</td>
<td align="left" rowspan="1" colspan="1">0.79 (0.70–0.87)</td>
<td align="left" rowspan="1" colspan="1">0.61 (0.50–0.72)</td>
<td align="left" rowspan="1" colspan="1">2.06 (1.54–2.74)</td>
<td align="left" rowspan="1" colspan="1">0.34 (0.22–0.51)</td>
<td align="left" rowspan="1" colspan="1">6.09 (3.19–11.60)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Vodnik T (2013) [<xref rid="pone.0133057.ref012" ref-type="bibr">12</xref>]</td>
<td align="left" rowspan="1" colspan="1">630</td>
<td align="left" rowspan="1" colspan="1">30</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">98</td>
<td align="left" rowspan="1" colspan="1">1.00 (0.88–1.00)</td>
<td align="left" rowspan="1" colspan="1">0.98 (0.93–1.00)</td>
<td align="left" rowspan="1" colspan="1">39.75 (11.68–135.31)</td>
<td align="left" rowspan="1" colspan="1">0.02 (0.00–0.26)</td>
<td align="left" rowspan="1" colspan="1">2403.40 (112.31–51433.97)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Shozushima T (2011) <xref rid="t005fn001" ref-type="table-fn"><sup>a</sup></xref> [<xref rid="pone.0133057.ref034" ref-type="bibr">34</xref>]</td>
<td align="left" rowspan="1" colspan="1">399</td>
<td align="left" rowspan="1" colspan="1">104</td>
<td align="left" rowspan="1" colspan="1">14</td>
<td align="left" rowspan="1" colspan="1">25</td>
<td align="left" rowspan="1" colspan="1">49</td>
<td align="left" rowspan="1" colspan="1">0.81 (0.73–0.87)</td>
<td align="left" rowspan="1" colspan="1">0.78 (0.66–0.87)</td>
<td align="left" rowspan="1" colspan="1">3.63 (2.27–5.80)</td>
<td align="left" rowspan="1" colspan="1">0.25 (0.17–0.36)</td>
<td align="left" rowspan="1" colspan="1">14.56 (6.97–30.43)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Shozushima T (2011) <xref rid="t005fn002" ref-type="table-fn"><sup>b</sup></xref> [<xref rid="pone.0133057.ref034" ref-type="bibr">34</xref>]</td>
<td align="left" rowspan="1" colspan="1">415</td>
<td align="left" rowspan="1" colspan="1">103</td>
<td align="left" rowspan="1" colspan="1">12</td>
<td align="left" rowspan="1" colspan="1">26</td>
<td align="left" rowspan="1" colspan="1">51</td>
<td align="left" rowspan="1" colspan="1">0.80 (0.72–0.86)</td>
<td align="left" rowspan="1" colspan="1">0.81 (0.69–0.90)</td>
<td align="left" rowspan="1" colspan="1">4.19 (2.50–7.03)</td>
<td align="left" rowspan="1" colspan="1">0.25 (0.17–0.36)</td>
<td align="left" rowspan="1" colspan="1">16.84 (7.86–36.07)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Overall outcome</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">0.78 (0.76–0.80)</td>
<td align="left" rowspan="1" colspan="1">0.83 (0.80–0.85)</td>
<td align="left" rowspan="1" colspan="1">4.63 (3.27–6.55)</td>
<td align="left" rowspan="1" colspan="1">0.22 (0.16–0.30)</td>
<td align="left" rowspan="1" colspan="1">21.73 (12.81–36.86)</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t005fn001"><p><sup>a</sup> Results of first of two trials in this article</p></fn>
<fn id="t005fn002"><p><sup>b</sup> Results of second of two trials in this article</p></fn>
<fn id="t005fn003"><p>TP: true positive; FP: false positive; FN: false negative; TN: true negative; Se: sensitivity; Sp: specificity; PLR: positive likelihood ratio; NLR: negative likelihood ratio; DOR: diagnostic odds ratio.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec016">
<title>Results of sensitivity analysis and publication bias</title>
<p>In the sensitivity analysis, the influence of each study on the pooled AUC was examined by omitting each study one at a time. Regardless which study was removed, the pooled AUC estimated by the remaining studies did not change significantly. This result indicated that no individual study dominated the results of the meta-analysis, thereby validating the credibility of the outcomes (<xref rid="pone.0133057.t006" ref-type="table">Table 6</xref>). To compare the diagnostic accuracy of presepsin for sepsis in studies with or without healthy controls, we also conducted a sensitivity analysis by obtaining data from 10 trials (6 trials provided data for controls with healthy people, and 4 provided data for controls without healthy people). When healthy people were included in controls with SIRS of non-infectious origin, the diagnostic accuracy was similar to that of including only SIRS without infection in controls as evaluated by AUC (0.90 [95% CI: 0.88 to 0.92] vs. 0.85 [95%CI: 0.82 to 0.88]; not tested for significance).</p>
<table-wrap id="pone.0133057.t006" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0133057.t006</object-id>
<label>Table 6</label> <caption><title>The pooled AUC and 95% CI after omitting each trial in the meta-analysis (The results of sensitivity analysis).</title></caption>
<alternatives>
<graphic id="pone.0133057.t006g" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0133057.t006" xlink:type="simple"/>
<table>
<colgroup span="1">
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
</colgroup>
<thead>
<tr>
<th align="left" rowspan="1" colspan="1">Study</th>
<th align="left" rowspan="1" colspan="1">AUC</th>
<th align="left" rowspan="1" colspan="1">95% CI</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Behnes M (2014)</td>
<td align="char" char="." rowspan="1" colspan="1">0.89</td>
<td align="left" rowspan="1" colspan="1">0.83–0.95</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Kweon OJ (2014)</td>
<td align="char" char="." rowspan="1" colspan="1">0.89</td>
<td align="left" rowspan="1" colspan="1">0.83–0.95</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Sargentini V (2014)</td>
<td align="char" char="." rowspan="1" colspan="1">0.90</td>
<td align="left" rowspan="1" colspan="1">0.84–0.96</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Su MH (2014)</td>
<td align="char" char="." rowspan="1" colspan="1">0.88</td>
<td align="left" rowspan="1" colspan="1">0.84–0.92</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Yu J (2014)</td>
<td align="char" char="." rowspan="1" colspan="1">0.89</td>
<td align="left" rowspan="1" colspan="1">0.82–0.96</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Liu B (2013)</td>
<td align="char" char="." rowspan="1" colspan="1">0.89</td>
<td align="left" rowspan="1" colspan="1">0.81–0.97</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Ulla M (2013)</td>
<td align="char" char="." rowspan="1" colspan="1">0.89</td>
<td align="left" rowspan="1" colspan="1">0.87–0.91</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Vodnik T (2013)</td>
<td align="char" char="." rowspan="1" colspan="1">0.88</td>
<td align="left" rowspan="1" colspan="1">0.84–0.92</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Shozushima T (2011)<xref rid="t006fn001" ref-type="table-fn"><sup>a</sup></xref></td>
<td align="char" char="." rowspan="1" colspan="1">0.90</td>
<td align="left" rowspan="1" colspan="1">0.84–0.96</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Shozushima T (2011)<xref rid="t006fn002" ref-type="table-fn"><sup>b</sup></xref></td>
<td align="char" char="." rowspan="1" colspan="1">0.89</td>
<td align="left" rowspan="1" colspan="1">0.83–0.95</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t006fn001"><p><sup>a</sup> Results of first of two trials in this article</p></fn>
<fn id="t006fn002"><p><sup>b</sup> Results of second of two trials in this article</p></fn>
<fn id="t006fn003"><p>AUC: the area under the summary receiver operating characteristic curve; CI: confidence interval.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>Publication bias was analyzed by funnel plot, Egger’s test, and Begg’s test, which provided negligible evidence of publication bias for the outcome of DOR (<italic>P</italic> value for Egger’s test = 0.140; <italic>P</italic> value for Begg’s test = 0.067). The funnel plot is shown in <xref rid="pone.0133057.g004" ref-type="fig">Fig 4</xref>.</p>
<fig id="pone.0133057.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0133057.g004</object-id>
<label>Fig 4</label>
<caption>
<title>Begg’s funnel plot of publication bias.</title>
<p>Each point represents a separate study.</p>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0133057.g004" position="float" xlink:type="simple"/>
</fig>
</sec>
</sec>
<sec id="sec017" sec-type="conclusions">
<title>Discussion</title>
<p>At present, various biomarkers (alone or in combination) are used in the diagnosis of sepsis, including procalcitonin (PCT), C-reactive protein (CRP), interleukin (IL), and soluble form of triggering receptor expressed on myeloid cells-1 (Strem-1). However, the clinical value of these biomarkers is still controversy. Moreover, blood culture is treated as the gold criteria for sepsis diagnosis, but it always takes 48–72 hours to obtain the outcome when this approach is used. Blood culture has a low positive rate, which results in diagnosis delay, and the best treatment time is missed. Therefore, finding a reliable biomarker for the early and rapid diagnosis of sepsis is critical.</p>
<p>A large number of studies have found that sCD14 has important pathophysiological implications in the occurrence and development of many human diseases. sCD14 exists in the blood and urine of humans, and comprises 99% of the total amount of CD14 in the human body, with a normal concentration of 2 to 6 μg/ml in serum [<xref rid="pone.0133057.ref035" ref-type="bibr">35</xref>]. sCD14 concentration is closely related to the level of endotoxin and plays a critical role on mediating the inflammatory reaction of endothelial and epithelial cells. As a subtype of sCD14, presepsin can signal a much earlier and faster increase of sepsis when compared with PCT. Hence, presepsin may be a useful diagnostic biomarker for sepsis. However, the results of the current studies on presepsin showed considerable differences, such as in the SE range (0.73–1.00) and in the SP range (0.44–0.98), which may be due to the differences in the sample populations and study designs, differences in the selection of people for the control, and differences in cut-off values. Therefore, a meta-analysis, which is useful in integrating results from independent studies for a specified outcome, was conducted to determine the pooled outcomes.</p>
<p>In our meta-analysis, 9 studies that represented 10 trials were included, of which the sample populations were collected from ICU, ED, and CCU, or were typically seen in medical, surgical, and traumatic. The findings of this meta-analysis were therefore applicable to common clinical settings in which critically ill patients were managed. In these studies, the diagnostic value of presepsin was evaluated by testing the level in blood sample of septic patients compared with that of patients with non sepsis. Blood samples were drawn at admission, or clinical onset, or before any treatment, and presepsin levels were measured by using a chemiluminescent enzyme immunoassay that allowed making automated measurements in a short time. The pooled results indicated that presepsin showed a moderate diagnostic value for distinguishing sepsis from non sepsis. However, systematic reviews of diagnostic accuracy studies are often characterized by a notable heterogeneity caused by the differences in the design and implementation of the studies. Thus, our results should be interpreted cautiously [<xref rid="pone.0133057.ref036" ref-type="bibr">36</xref>].</p>
<p>First, non-infectious SIRS patients were assessed as controls in each study, which is difficult to distinguish from sepsis because the clinical signs often overlap between them. However, healthy people also served as controls in some included studies, which may make the pooled outcomes much higher than the real results. Then we conducted a sensitivity analysis to make an exact evaluation, but the results had not changed much in the index of AUC compared with the overall AUC (0.89 [95%CI: 0.84 to 0.94] vs. 0.85 [95%CI: 0.82 to 0.88]), thus, the including of healthy people seemed to have little influence on the overall outcomes. But further study designed with better homogeneity is advisable.</p>
<p>Second, the cutoff values of presepsin among these included studies varied greatly, even though using the same test method. The difference may lie in the admission category, number of cases, and sample timing. Therefore, this research was limited in terms of qualitative analysis, but not in terms of quantitative analysis.</p>
<p>Third, all included studies declared that infection was confirmed by microbiologically or clinically according to an internationally recognized gold standard, but most failed to provide the information about whether previous antibacterial treatment was used. Under the impact of antibiotic drugs, bacteraemia occurs in only 30% of patients with sepsis [<xref rid="pone.0133057.ref037" ref-type="bibr">37</xref>, <xref rid="pone.0133057.ref038" ref-type="bibr">38</xref>]. Moreover, the level of presepsin decreased rapidly after treatment [<xref rid="pone.0133057.ref028" ref-type="bibr">28</xref>]. Thus, the absence of such therapeutic details may increase interobserver variability, and add false judgment about the patient’s medical condition [<xref rid="pone.0133057.ref004" ref-type="bibr">4</xref>].</p>
<p>Fourth, extreme heterogeneity existed among these included studies. We detected substantial heterogeneity by bringing the study characteristics and clinical natures into meta-regression analysis, but none of them was responsible for the majority of heterogeneity. Thus, some unrecorded difference may contribute to the heterogeneity, and a study with better design and more homogenous population is needed to avoid the heterogeneity.</p>
<p>Fifth, LPS is a component of the Gram-negative bacterial cell wall. As a receptor of LPS, presepsin is easy to imagine that whether it only work for Gram-negative infections. Studies have shown that the Se of presepsin was not significantly different between Gram-positive and Gram-negative bacterial infections [<xref rid="pone.0133057.ref017" ref-type="bibr">17</xref>, <xref rid="pone.0133057.ref039" ref-type="bibr">39</xref>, <xref rid="pone.0133057.ref040" ref-type="bibr">40</xref>], while no disparity of presepsin concentration was found among the infection caused by Gram-positive or Gram-negative bacterial infections [<xref rid="pone.0133057.ref030" ref-type="bibr">30</xref>]. So it seems to be lack of evidence to prove that presepsin is not a predicator only for sepsis induced by Gram-negative cocci infection.</p>
<p>In previous clinical practices, many biomarkers were widely applied in diagnosis of sepsis, and PCT is the most widely used one. Several evidence-based researches have proved that PCT had a low diagnostic performance in differentiating sepsis from critically ill patients, and can not be recommended as the single definitive test for sepsis diagnosis [<xref rid="pone.0133057.ref004" ref-type="bibr">4</xref>, <xref rid="pone.0133057.ref041" ref-type="bibr">41</xref>, <xref rid="pone.0133057.ref042" ref-type="bibr">42</xref>]. When compared to PCT, presepsin also showed a similar diagnostic accuracy for sepsis with respect to Se (0.78 [95% CI: 0.76 to 0.80] vs. 0.77 [95% CI: 0.72 to 0.81]), Sp (0.83 [95% CI: 0.80 to 0.85] vs. 0.79 [95% CI: 0.74 to 0.84]), AUC (0.89 [95% CI: 0.84 to 0.94] vs. 0.85 [95% CI: 0.81 to 0.88]), according to a latest evidence about the accuracy of PCT for differentiating sepsis from SIRS without infection [<xref rid="pone.0133057.ref004" ref-type="bibr">4</xref>]. To avoid the bias of results raised by including healthy people in the research, we conducted a sensitivity analysis to exclude these studies. From the results of sensitivity analysis, we noted that, when focused on studies aimed at discriminating sepsis from non-infectious SIRS, the accuracy of presepsin was the same to that of PCT, with respect to AUC (0.85 [95% CI: 0.82 to 0.88] vs. 0.85 [95% CI: 0.81 to 0.88]). Whether a marker can be used alone for the diagnosis of sepsis depends on its diagnostic performance. Therefore, presepsin did not show any advantage in diagnostic performance of sepsis compared to PCT, and it cannot be recommended as a single definitive test for sepsis diagnosis. However, presepsin showed some superiority in the management of patients, such as both presepsin and PCT are elevated in non-infectious SIRS and sepsis, but presepsin can signal a much earlier and faster increase in sepsis, and perform a unique capacity of distinguishing the severity of sepsis [<xref rid="pone.0133057.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0133057.ref012" ref-type="bibr">12</xref>, <xref rid="pone.0133057.ref033" ref-type="bibr">33</xref>]. Furthermore, by using the PATHFAST analysis system, presepsin test only takes 17 min and can be conducted at bedside, thereby complying with the guidelines for the diagnosis and treatment of sepsis [<xref rid="pone.0133057.ref001" ref-type="bibr">1</xref>]. Consequently, although presepsin showed a moderate diagnostic accuracy which was similar to PCT, but it was still a helpful biomarker for early diagnosis of sepsis and severity evaluation.</p>
<p>In addition, other limitations are present. First, the search range was limited in published studies, which means we might have missed some unpublished, but valuable studies. Second, diagnostic tests were generally designed in case-control study or cross-sectional study, which belonged to the third level design in evidence-based medicine. Thus, many studies in this area were not designed with a blind method or did not clearly use the blind method to strengthen the argument, which may have contributed to the possibility of bias [<xref rid="pone.0133057.ref043" ref-type="bibr">43</xref>, <xref rid="pone.0133057.ref044" ref-type="bibr">44</xref>]. Third, this systemic review did not investigate the prognostic value of presepsin in sepsis because not enough evidence is available.</p>
<p>In conclusion, presepsin had some superiority in the management of patients, and may be a helpful and valuable biomarker in early diagnosis of sepsis. However, presepsin showed a moderate diagnostic accuracy in differentiating sepsis from non-sepsis which prevented it from being recommended as a definitive test for diagnosing sepsis in isolation, but the results should be interpreted cautiously due to the heavy heterogeneity and different clinical natures in these included studies. Moreover, further randomized controlled researches are required in the context with unified clinical information.</p>
</sec>
<sec id="sec018">
<title>Supporting Information</title>
<supplementary-material id="pone.0133057.s001" xlink:href="info:doi/10.1371/journal.pone.0133057.s001" mimetype="application/msword" position="float" xlink:type="simple">
<label>S1 Checklist</label>
<caption>
<title>Prisma checklist.</title>
<p>(DOC)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0133057.s002" xlink:href="info:doi/10.1371/journal.pone.0133057.s002" mimetype="application/msword" position="float" xlink:type="simple">
<label>S1 Table</label>
<caption>
<title>Details of QUADAS-2 quality assessment for each study.</title>
<p>This table presented the details of quality assessment for each study by the QUADAS-2 tool.</p>
<p>(DOC)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>This study was funded by the Scientific and Technological Innovation Project of Educational Commission of Guangdong Province (Grant No. 2013KJCX0092).</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pone.0133057.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zou</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Wen</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>XC</given-names></name>. (<year>2014</year>) <article-title>Presepsin as a novel sepsis biomarker</article-title>. <source>World J Emerg Med</source> <volume>5</volume>:<fpage>16</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.5847/wjem.j.1920-8642.2014.01.002" xlink:type="simple">10.5847/wjem.j.1920-8642.2014.01.002</ext-link></comment> <object-id pub-id-type="pmid">25215141</object-id></mixed-citation></ref>
<ref id="pone.0133057.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dombrovskiy</surname> <given-names>VY</given-names></name>, <name name-style="western"><surname>Martin</surname> <given-names>AA</given-names></name>, <name name-style="western"><surname>Sunderram</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Paz</surname> <given-names>HL</given-names></name>. (<year>2007</year>) <article-title>Rapid increase in hospitalization and mortality rates for severe sepsis in the United State: a trend analysis from 1993 to 2003</article-title>. <source>Crit Care Med</source> <volume>35</volume>:<fpage>1244</fpage>–<lpage>50</lpage>. <object-id pub-id-type="pmid">17414736</object-id></mixed-citation></ref>
<ref id="pone.0133057.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vincent</surname> <given-names>JL</given-names></name>, <name name-style="western"><surname>Rello</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Marshall</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Silva</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Anzueto</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Martin</surname> <given-names>CD</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>International study of the prevalence and outcome of infection in intensive care unite</article-title>. <source>JAMA</source> <volume>302</volume>:<fpage>2323</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1001/jama.2009.1754" xlink:type="simple">10.1001/jama.2009.1754</ext-link></comment> <object-id pub-id-type="pmid">19952319</object-id></mixed-citation></ref>
<ref id="pone.0133057.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Walker</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Prkno</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Brunkhorst</surname> <given-names>FM</given-names></name>, <name name-style="western"><surname>Schlattmann</surname> <given-names>P</given-names></name>. (<year>2013</year>) <article-title>Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis</article-title>. <source>Lancte Infect Dis</source> <volume>13</volume>:<fpage>426</fpage>–<lpage>35</lpage>.</mixed-citation></ref>
<ref id="pone.0133057.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Balci</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Sungurtekin</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Gurses</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Sungurtekin</surname> <given-names>U</given-names></name>, <name name-style="western"><surname>Kaptanoglu</surname> <given-names>B</given-names></name>. (<year>2003</year>) <article-title>Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit</article-title>. <source>Crit Care</source> <volume>7</volume>:<fpage>85</fpage>–<lpage>90</lpage>. <object-id pub-id-type="pmid">12617745</object-id></mixed-citation></ref>
<ref id="pone.0133057.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>HW</given-names></name>, <name name-style="western"><surname>Liang</surname> <given-names>DY</given-names></name>, <name name-style="western"><surname>Hou</surname> <given-names>YQ</given-names></name>. (<year>2014</year>) <article-title>Progress of prognostic markers in sepsis</article-title>. <source>Int J Lab Med</source> <volume>35</volume>:<fpage>2794</fpage>–<lpage>6</lpage>.</mixed-citation></ref>
<ref id="pone.0133057.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Behnes</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Bertsch</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Lepiorz</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Lang</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Trinkmann</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Brueckmann</surname> <given-names>M</given-names></name>, <etal>et al</etal>. (<year>2014</year>) <article-title>Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment</article-title>. <source>Crit Care</source> <volume>18</volume>:<fpage>507</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/s13054-014-0507-z" xlink:type="simple">10.1186/s13054-014-0507-z</ext-link></comment> <object-id pub-id-type="pmid">25190134</object-id></mixed-citation></ref>
<ref id="pone.0133057.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sandquist</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Wong</surname> <given-names>HR</given-names></name>. (<year>2014</year>) <article-title>Biomarkers of sepsis and their potential value in diagnosis, prognosis and treatment</article-title>. <source>Clin Immunol</source> <volume>10</volume>:<fpage>1349</fpage>–<lpage>1356</lpage>.</mixed-citation></ref>
<ref id="pone.0133057.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mussap</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Noto</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Fravega</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Fanos</surname> <given-names>V</given-names></name>. (<year>2011</year>) <article-title>Soluble CD14 subtype presepsin (sCD14-ST) and lipopolysaccharide binding protein (LBP) in neonatal sepsis: new clinical and analytical perspectives for two old biamarkers</article-title>. <source>J Matern Fetal Neonatal Med</source> <volume>24</volume>:<fpage>12</fpage>–<lpage>14</lpage>.</mixed-citation></ref>
<ref id="pone.0133057.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yaegashi</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Shirakawa</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Sato</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Suzuki</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Kojika</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Imai</surname> <given-names>S</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis</article-title>. <source>J Infect Chemother</source> <volume>11</volume>:<fpage>234</fpage>–<lpage>238</lpage>. <object-id pub-id-type="pmid">16258819</object-id></mixed-citation></ref>
<ref id="pone.0133057.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Palmiere</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Mussap</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Bardy</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Cibecchini</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Mangin</surname> <given-names>P</given-names></name>. (<year>2013</year>) <article-title>Diagnostic value of soluble CD14 subtype (sCD14-ST) presepsin for the postmortem diagnosis of sepsis-related fatalities</article-title>. <source>Int J Legal Med</source> <volume>127</volume>:<fpage>799</fpage>–<lpage>808</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00414-012-0804-5" xlink:type="simple">10.1007/s00414-012-0804-5</ext-link></comment> <object-id pub-id-type="pmid">23263410</object-id></mixed-citation></ref>
<ref id="pone.0133057.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vodnik</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Kaljevic</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Tadic</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Majkic-Singh</surname> <given-names>N</given-names></name>. (<year>2013</year>) <article-title>Presepsin (sCD14-ST) in preoperative diagnosis of abdominal sepsis</article-title>. <source>Clin Chem Lab Med</source> <volume>51</volume>:<fpage>2053</fpage>–<lpage>2062</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1515/cclm-2013-0061" xlink:type="simple">10.1515/cclm-2013-0061</ext-link></comment> <object-id pub-id-type="pmid">23740685</object-id></mixed-citation></ref>
<ref id="pone.0133057.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gatsonis</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Paliwal</surname> <given-names>P</given-names></name>. (<year>2006</year>) <article-title>Meta-analysis of diagnostic and screening test accuracy evaluations: methodologic primer</article-title>. <source>AJR Am J Roentgenol</source> <volume>187</volume>:<fpage>271</fpage>–<lpage>281</lpage>. <object-id pub-id-type="pmid">16861527</object-id></mixed-citation></ref>
<ref id="pone.0133057.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moher</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Liberati</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Tetzlaff</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Altman</surname> <given-names>DG</given-names></name>, <collab xlink:type="simple">PRISMA group</collab>. (<year>2010</year>) <article-title>Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement</article-title>. <source>Int J Surg</source> <volume>8</volume>:<fpage>336</fpage>–<lpage>341</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ijsu.2010.02.007" xlink:type="simple">10.1016/j.ijsu.2010.02.007</ext-link></comment> <object-id pub-id-type="pmid">20171303</object-id></mixed-citation></ref>
<ref id="pone.0133057.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><collab xlink:type="simple">ACCP/SCCM Consensus Conference Committee</collab>. (<year>1992</year>) <article-title>Definitions for sepsis and organ failure and guidelines for use of innovate therapies in sepsis</article-title>. <source>Crit Care Med</source> <volume>20</volume>:<fpage>867</fpage>–<lpage>874</lpage>.</mixed-citation></ref>
<ref id="pone.0133057.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Levy</surname> <given-names>MM</given-names></name>, <name name-style="western"><surname>Fink</surname> <given-names>MP</given-names></name>, <name name-style="western"><surname>Marshall</surname> <given-names>JC</given-names></name>, <name name-style="western"><surname>Abraham</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Angus</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Cook</surname> <given-names>D</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>International Sepsis Definitions Conference, 2001 SCCM/ESICM/ACCP/ATS/SIS</article-title>. <source>Intensive Care Med</source> <volume>29</volume>:<fpage>530</fpage>–<lpage>538</lpage>. <object-id pub-id-type="pmid">12664219</object-id></mixed-citation></ref>
<ref id="pone.0133057.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dellinger</surname> <given-names>RP</given-names></name>, <name name-style="western"><surname>Levy</surname> <given-names>MM</given-names></name>, <name name-style="western"><surname>Carlet</surname> <given-names>JM</given-names></name>. (<year>2008</year>) <article-title>Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock</article-title>. <source>Crit Care Med</source> <volume>36</volume>: <fpage>296</fpage>–<lpage>327</lpage>. <object-id pub-id-type="pmid">18158437</object-id></mixed-citation></ref>
<ref id="pone.0133057.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Whiting</surname> <given-names>PF</given-names></name>, <name name-style="western"><surname>Rutjes</surname> <given-names>AW</given-names></name>, <name name-style="western"><surname>Westwood</surname> <given-names>ME</given-names></name>, <name name-style="western"><surname>Mallett</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Deeks</surname> <given-names>JJ</given-names></name>, <name name-style="western"><surname>Reitsma</surname> <given-names>JB</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies</article-title>. <source>Ann Intern Med</source> <volume>155</volume>:<fpage>529</fpage>–<lpage>536</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.7326/0003-4819-155-8-201110180-00009" xlink:type="simple">10.7326/0003-4819-155-8-201110180-00009</ext-link></comment> <object-id pub-id-type="pmid">22007046</object-id></mixed-citation></ref>
<ref id="pone.0133057.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zamora</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Abraira</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Muriel</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Khan</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Coomarasamy</surname> <given-names>A</given-names></name>. (<year>2006</year>) <article-title>Meta-DiSc: a software for meta-analysis of test accuracy data</article-title>. <source>BMC Med Res Methodol</source> <volume>6</volume>:<fpage>31</fpage>. <object-id pub-id-type="pmid">16836745</object-id></mixed-citation></ref>
<ref id="pone.0133057.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lijmer</surname> <given-names>JG</given-names></name>, <name name-style="western"><surname>Bossuyt</surname> <given-names>PM</given-names></name>, <name name-style="western"><surname>Heisteikamp</surname> <given-names>SH</given-names></name>. (<year>2002</year>) <article-title>Exploring sources of heterogeneity in systematic reviews of diagnostic tests</article-title>. <source>Stat Med</source> <volume>21</volume>:<fpage>1525</fpage>–<lpage>1537</lpage>. <object-id pub-id-type="pmid">12111918</object-id></mixed-citation></ref>
<ref id="pone.0133057.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mantel</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Haenszel</surname> <given-names>W</given-names></name>. (<year>1959</year>) <article-title>Statistical aspects of the analysis of data from retrospective studies of disease</article-title>. <source>J Natl Cancer Inst</source> <volume>22</volume>:<fpage>719</fpage>–<lpage>748</lpage>. <object-id pub-id-type="pmid">13655060</object-id></mixed-citation></ref>
<ref id="pone.0133057.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Walker</surname> <given-names>SD</given-names></name>. (<year>2002</year>) <article-title>Properies of the summary receiver operating characteristic (SROC) curve for diagnostic test data</article-title>. <source>Stat Med</source> <volume>15</volume>:<fpage>1237</fpage>–<lpage>1256</lpage>.</mixed-citation></ref>
<ref id="pone.0133057.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gatsonia</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Paliwal</surname> <given-names>P</given-names></name>. (<year>2006</year>) <article-title>Meta-analysis of diagnostic and screening test accuracy evaluations: methodologic primer</article-title>. <source>AJR Am J Roentgenol</source> <volume>187</volume>:<fpage>271</fpage>–<lpage>281</lpage>. <object-id pub-id-type="pmid">16861527</object-id></mixed-citation></ref>
<ref id="pone.0133057.ref024"><label>24</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Dwamena</surname> <given-names>B</given-names></name>. (<year>2007</year>) <chapter-title>MIDAS: Stata module for meta-analytical integration of diagnostic test accuracy studies</chapter-title>. <source>Statistical Software Components S456880</source>. <publisher-loc>Boston, MA</publisher-loc>: <publisher-name>Boston College Department of Econonics</publisher-name>.</mixed-citation></ref>
<ref id="pone.0133057.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cargnin</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Jommi</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Canonico</surname> <given-names>PL</given-names></name>, <name name-style="western"><surname>Genazzani</surname> <given-names>AA</given-names></name>, <name name-style="western"><surname>Terrazzino</surname> <given-names>S</given-names></name>. (<year>2014</year>) <article-title>Diagnostic accuracy of HLA-B*57:01 screening for the prediction of abacavir hypersensitivity and clinical utility of the test: a meta-analysis review</article-title>. <source>Pharmacogenonics</source> <volume>15</volume>:<fpage>963</fpage>–<lpage>976</lpage>.</mixed-citation></ref>
<ref id="pone.0133057.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Egger</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Davey</surname> <given-names>SG</given-names></name>, <name name-style="western"><surname>Schneider</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Minder</surname> <given-names>C</given-names></name>. (<year>1997</year>) <article-title>Bias in meta-analysis detected by a simple, graphical test</article-title>. <source>BMJ</source> <volume>315</volume>: <fpage>629</fpage>–<lpage>634</lpage>. <object-id pub-id-type="pmid">9310563</object-id></mixed-citation></ref>
<ref id="pone.0133057.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Begg</surname> <given-names>CB</given-names></name>, <name name-style="western"><surname>Mazumdar</surname> <given-names>M</given-names></name>. (<year>1994</year>) <article-title>Operating characteristics of a rank correlation test for publication bias</article-title>. <source>Biametrics</source> <volume>50</volume>:<fpage>1088</fpage>–<lpage>1101</lpage>.</mixed-citation></ref>
<ref id="pone.0133057.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kweon</surname> <given-names>OJ</given-names></name>, <name name-style="western"><surname>Choi</surname> <given-names>JH</given-names></name>, <name name-style="western"><surname>Park</surname> <given-names>SK</given-names></name>, <name name-style="western"><surname>Park</surname> <given-names>AJ</given-names></name>. (<year>2014</year>) <article-title>Usefulness of presepsin (sCD14 subtype) measurements as a new marker for the diagnosis and prediction of disease severity of sepsis in the Korean population</article-title>. <source>J Crit Care</source> <volume>29</volume>:<fpage>965</fpage>–<lpage>970</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jcrc.2014.06.014" xlink:type="simple">10.1016/j.jcrc.2014.06.014</ext-link></comment> <object-id pub-id-type="pmid">25042676</object-id></mixed-citation></ref>
<ref id="pone.0133057.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sargentini</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Ceccarelli</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>D’Alessandro</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Collepardo</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Morelli</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>D’Eqidio</surname> <given-names>A</given-names></name>, <etal>et al</etal>. (<year>2014</year>) <article-title>Presepsin as a potential marker for bacterial infection relapse in critical care patients: A preliminary study</article-title>. <source>Clin Chem Lab Med</source>. <volume>53</volume>:<fpage>567</fpage>–<lpage>573</lpage>.</mixed-citation></ref>
<ref id="pone.0133057.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Su</surname> <given-names>MH</given-names></name>, <name name-style="western"><surname>Shou</surname> <given-names>ST</given-names></name>. (<year>2014</year>) <article-title>Prognostic value of presepsin for diagnosis and severity assessment of sepsis</article-title>. <source>Chin J Clin Lab Sci</source> <volume>32</volume>:<fpage>106</fpage>–<lpage>111</lpage>.</mixed-citation></ref>
<ref id="pone.0133057.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yu</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Shao</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>XH</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>K</given-names></name>. (<year>2014</year>) <article-title>Combined determination of presepsin, procalcitonin and C reactive protein for early diagnosis and prognostic assessment of severe trauma patients with sepsis</article-title>. <source>Chin J Clin Lab Sci</source> <volume>32</volume>:<fpage>200</fpage>–<lpage>203</lpage>.</mixed-citation></ref>
<ref id="pone.0133057.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>YX</given-names></name>, <name name-style="western"><surname>Yin</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Zhao</surname> <given-names>YZ</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>CS</given-names></name>. (<year>2013</year>) <article-title>Diagnostic value and prognostic evaluation of presepsin for sepsis in an emergency department</article-title>. <source>Crit Care</source> <volume>17</volume>:<fpage>R244</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/cc13070" xlink:type="simple">10.1186/cc13070</ext-link></comment> <object-id pub-id-type="pmid">24138799</object-id></mixed-citation></ref>
<ref id="pone.0133057.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ulla</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Pizzolato</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Lucchiari</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Loiacono</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Soardo</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Forno</surname> <given-names>D</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study</article-title>. <source>Crit Care</source> <volume>17</volume>:<fpage>R168</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/cc12847" xlink:type="simple">10.1186/cc12847</ext-link></comment> <object-id pub-id-type="pmid">23899120</object-id></mixed-citation></ref>
<ref id="pone.0133057.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shozushima</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Takahashi</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Matsumoto</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Kojika</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Okamura</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Endo</surname> <given-names>S</given-names></name>. (<year>2011</year>) <article-title>Usefulness of presepsin (sCD14-ST) measurement as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome</article-title>. <source>J Infect Chemother</source> <volume>17</volume>:<fpage>764</fpage>–<lpage>769</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s10156-011-0254-x" xlink:type="simple">10.1007/s10156-011-0254-x</ext-link></comment> <object-id pub-id-type="pmid">21560033</object-id></mixed-citation></ref>
<ref id="pone.0133057.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shirakawa</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Naitou</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Hirose</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Takahashi</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Furusako</surname> <given-names>S</given-names></name>. (<year>2011</year>) <article-title>Presepsin (sCD14-ST): development and evaluation of one-step ELISA with a new standard that is similar to the form of presepsin in sepsis patients</article-title>. <source>Clin Chem Lab Med</source> <volume>49</volume>:<fpage>937</fpage>–<lpage>939</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1515/CCLM.2011.145" xlink:type="simple">10.1515/CCLM.2011.145</ext-link></comment> <object-id pub-id-type="pmid">21345045</object-id></mixed-citation></ref>
<ref id="pone.0133057.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Whiting</surname> <given-names>PF</given-names></name>, <name name-style="western"><surname>Rutjes</surname> <given-names>AW</given-names></name>, <name name-style="western"><surname>Reitsma</surname> <given-names>JB</given-names></name>, <name name-style="western"><surname>Bossuyt</surname> <given-names>PM</given-names></name>, <name name-style="western"><surname>Kleijnen</surname> <given-names>J</given-names></name>. (<year>2003</year>) <article-title>The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews</article-title>. <source>BMC Med Methodol</source> <volume>3</volume>:<fpage>25</fpage>.</mixed-citation></ref>
<ref id="pone.0133057.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bates</surname> <given-names>DW</given-names></name>, <name name-style="western"><surname>Cook</surname> <given-names>EF</given-names></name>, <name name-style="western"><surname>Goldman</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>TH</given-names></name>. (<year>1990</year>) <article-title>Predicting bacteremia in hospitalized patients. A prospectively validated model</article-title>. <source>Ann Intern Med</source> <volume>113</volume>:<fpage>495</fpage>–<lpage>500</lpage>. <object-id pub-id-type="pmid">2393205</object-id></mixed-citation></ref>
<ref id="pone.0133057.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bates</surname> <given-names>DW</given-names></name>, <name name-style="western"><surname>Sands</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Miller</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Lanker</surname> <given-names>PN</given-names></name>, <name name-style="western"><surname>Hibberd</surname> <given-names>PL</given-names></name>, <name name-style="western"><surname>Graman</surname> <given-names>PS</given-names></name>, <etal>et al</etal>. (<year>1997</year>) <article-title>Predicting bacteremia in patients with sepsis syndrome. Academic Medical Center Consortium Sepsis Preject Working Group</article-title>. <source>J Infect Dis</source> <volume>176</volume>:<fpage>1538</fpage>–<lpage>1551</lpage>. <object-id pub-id-type="pmid">9395366</object-id></mixed-citation></ref>
<ref id="pone.0133057.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Endo</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Suzuki</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Takahashi</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Shouzushima</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Ishikura</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Murai</surname> <given-names>A</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study</article-title>. <source>J Infect Chmother</source> <volume>18</volume>: <fpage>891</fpage>–<lpage>897</lpage>.</mixed-citation></ref>
<ref id="pone.0133057.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Okamura</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Yokoi</surname> <given-names>H</given-names></name>. (<year>2011</year>) <article-title>Development of a point-of-care assay system for measurement of presepsin (sCD14-ST)</article-title>. <source>Clin Chim Acta</source> <volume>412</volume>: <fpage>2157</fpage>–<lpage>2161</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.cca.2011.07.024" xlink:type="simple">10.1016/j.cca.2011.07.024</ext-link></comment> <object-id pub-id-type="pmid">21839732</object-id></mixed-citation></ref>
<ref id="pone.0133057.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tang</surname> <given-names>BM</given-names></name>, <name name-style="western"><surname>Eslick</surname> <given-names>GD</given-names></name>, <name name-style="western"><surname>Craig</surname> <given-names>JC</given-names></name>, <name name-style="western"><surname>McLean</surname> <given-names>AS</given-names></name>. (<year>2007</year>) <article-title>Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis</article-title>. <source>Lancet Infect Dis</source> <volume>7</volume>: <fpage>210</fpage>–<lpage>217</lpage>. <object-id pub-id-type="pmid">17317602</object-id></mixed-citation></ref>
<ref id="pone.0133057.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lee</surname> <given-names>SH</given-names></name>, <name name-style="western"><surname>Chan</surname> <given-names>RC</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>JY</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>HW</given-names></name>, <name name-style="western"><surname>Chang</surname> <given-names>SS</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>CC</given-names></name>. (<year>2013</year>) <article-title>Diagnostic value of procalcitonin for bacterial infection in elderly patients- a systemic review and meta-analysis</article-title>. <source>Int J Clin Pract</source> <volume>67</volume>:<fpage>1350</fpage>–<lpage>1357</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/ijcp.12278" xlink:type="simple">10.1111/ijcp.12278</ext-link></comment> <object-id pub-id-type="pmid">24246214</object-id></mixed-citation></ref>
<ref id="pone.0133057.ref043"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nismman</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Biran</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Ramu</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Heching</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Barak</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Peretz</surname> <given-names>t</given-names></name>. (<year>2009</year>) <article-title>The diagnostic and prognostic value of ProGRP in lung cancer</article-title>. <source>Anticancer Res</source> <volume>29</volume>:<fpage>4827</fpage>–<lpage>4832</lpage>. <object-id pub-id-type="pmid">20032442</object-id></mixed-citation></ref>
<ref id="pone.0133057.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lamy</surname> <given-names>PJ</given-names></name>, <name name-style="western"><surname>Grenier</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Kramar</surname> <given-names>A</given-names></name>. (<year>2000</year>) <article-title>Pro-gastin-releasing peptide, neuron specific enolase and chromogranin A as serum markers of small cell lung cancer</article-title>. <source>Lung Cancer</source> <volume>29</volume>:<fpage>197</fpage>–<lpage>203</lpage>. <object-id pub-id-type="pmid">10996422</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>